KLK3 and prostate carcinoma: We sought to understand the association between the 2012 USPSTF Grade D recommendation against PSA screening for all men and prostate cancer–specific mortality (PCSM) using contemporary, comprehensive, population-based nationwide data between 1999 and 2019, comparing mortality rates before and after the 2012 change to the screening guidelines.